Patients with mild to moderate Alzheimer's disease who were treated with the experimental drug Dimebon from US drugmaker Medivation Inc, showed improvement in key mental skills after a year compared to patients who took the placebo. The patients on the active drug showed clear improvements in memory, language, awareness of time and place, and a more complex process called "praxis", which means having an idea and then actually putting it into practice.
Read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment